Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 80

Cat.No. Product Name Information/Activity
BCC2459 DL-AP3 Phosphoserine phosphatase inhibitor
BCC5915 Bay 36-7620 Non-competitive mGlu<sub>1</sub> antagonist with inverse agonist activity
BCC6607 (S)-3-Carboxy-4-hydroxyphenylglycine 55136-48-6
BCC6600 (S)-4-Carboxy-3-hydroxyphenylglycine 85148-82-9
BCC6603 (S)-4-Carboxyphenylglycine 134052-73-6
BCC6896 CPCCOEt 179067-99-3
BCC6888 E4CPG E4CPG is a novel group I/group II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG .
BCC7345 Fenobam Fenobam is a selective, orally active, and non-competitive mGluR5 antagonist acting at an allosteric modulatory site (Kd values are 54 and 31 nM for rat and human recombinant mGlu5 receptors, respectively). Fenobam displays inverse agonist activity which blocks the mGlu5 receptor basal activity with an IC50 of 84 nM. Fenobam exerts anxiolytic activity.
BCC7166 HexylHIBO 334887-43-3
BCC7167 (S)-HexylHIBO 334887-48-8